Abstract
Apoptosis is one essential step for neuronal death in the nigrostriatal region in patients with Parkinson's disease. Cytotoxic tumor necrosis factor-α (TNF-α) and the proinflammatory cytokine interleukin-6 (Il-6) provide a proapoptotic environment. We investigated the influence of the antiparkinsonian compound budipine on the release of TNF-α and Il-6 in peripheral blood mononuclear cells (PBMC) and on the degree of cisplatin induced apoptotic cell death in SH-SY 5Y human neuroblastoma cells. 10-7, 10-8, 10-9 mol/l of budipine significantly reduced release of TNF-α and Il-6 in PBMC and decreased apoptotic cell death after 50 hours and 74 hours in the SH-SY 5Y cells. Our results suggest, that budipine administration provides an antiapoptotic environment and slows neuronal apoptotic and inflammatory mediated loss of neurons.
| Original language | English |
|---|---|
| Pages (from-to) | 1365-1373 |
| Number of pages | 9 |
| Journal | Journal of Neural Transmission |
| Volume | 111 |
| Issue number | 10-11 |
| DOIs | |
| Publication status | Published - Oct 2004 |
| Externally published | Yes |
Keywords
- Alzheimer's disease
- Apoptosis
- Budipine
- Interleukin-6
- Neurodegeneration
- Neuroprotection
- Parkinson's disease
- Tumor necrosis factor-α
Fingerprint
Dive into the research topics of 'Antiapoptotic effects of budipine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver